evaluation committee members

https://www.nice.org.uk/guidance/ta1036/chapter/5-Evaluation-committee-members-and-NICE-project-team 5 Evaluation committee members and NICE project team | Elacestrant for treating oestrogen... Evidence-based recommendations on elacestrant (Korserdu) for treating oestrogen receptor-positive HER2-negative advanced breast cancer with an ESR1 mutation... evaluation committee members https://www.nice.org.uk/guidance/TA921/chapter/5-evaluation-committee-members-and-nice-project-team 5 Evaluation committee members and NICE project team | Ruxolitinib for treating polycythaemia vera... Evidence-based recommendations on ruxolitinib (Jakavi) for polycythaemia vera in adults evaluation committee members https://www.nice.org.uk/guidance/ta864/chapter/5-Evaluation-committee-members-and-NICE-project-team 5 Evaluation committee members and NICE project team | Nintedanib for treating idiopathic pulmonary... Nintedanib for treating idiopathic pulmonary fibrosis when forced vital capacity is above 80% predicted evaluation committee members https://www.nice.org.uk/guidance/ta1037/chapter/5-Evaluation-committee-members-and-NICE-project-team 5 Evaluation committee members and NICE project team | Pembrolizumab for adjuvant treatment of... Evidence-based recommendations on pembrolizumab (Keytruda) for the adjuvant treatment of resected non-small-cell lung cancer in adults evaluation committee members https://www.nice.org.uk/guidance/ta956/chapter/4-Evaluation-committee-members-and-NICE-project-team 4 Evaluation committee members and NICE project team | Etrasimod for treating moderately to... Evidence-based recommendations on etrasimod (Velsipity) for moderately to severely active ulcerative colitis in people aged 16 and over evaluation committee members https://www.nice.org.uk/guidance/hst20/chapter/5-Evaluation-committee-members-and-NICE-project-team 5 Evaluation committee members and NICE project team | Selumetinib for treating symptomatic and... Evidence-based recommendations on selumetinib (Koselugo) for treating symptomatic and inoperable plexiform neurofibromas associated with type 1... evaluation committee members https://www.nice.org.uk/guidance/TA1018/chapter/5-evaluation-committee-members-and-nice-project-team 5 Evaluation committee members and NICE project team | Fedratinib for treating disease-related... Evidence-based recommendations on fedratinib (Inrebic) for treating disease-related splenomegaly or symptoms of primary myelofibrosis, post-polycythaemia vera... evaluation committee members https://www.nice.org.uk/guidance/TA1016/chapter/5-evaluation-committee-members-and-nice-project-team 5 Evaluation committee members and NICE project team | Elafibranor for previously treated primary... Evidence-based recommendations on elafibranor (Iqirvo) for previously treated primary biliary cholangitis in adults evaluation committee members

Robuta